Global ADME Toxicology Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2016 to 2022

  • ID: 4313357
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Beckman Coulter, Inc.
  • Cellartis AB
  • Cyprotex PLC
  • Molecular Discovery Ltd.
  • Promega Corporation
  • MORE
Global ADME Toxicology Testing Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022, the ADME toxicology testing was valued at USD 6,986.2 Mn in 2015, and is expected to reach USD 14,319.9 Mn by 2022, expanding at a CAGR of 10.6% from 2016 to 2022.

Market Insights
ADME is the abbreviation for absorption distribution, metabolism and elimination, a pharmacology and pharmacokinetics term that describes the disposition of a drug or compound inside the human body. ADME comprises set of four processes that develop the performance of a drug on human tissue and ADME toxicology testing is applied for the development of a new drug. ADME toxicology facilitated pharmaceutical manufacturing company to minimize their drug discovery time, testing complications, and to reduce the cost of drug development. The growing application of ADME toxicology testing by pharmaceuticals and biotechnology companies is assisting the market growth of the ADME toxicology testing market. One of the key factors responsible for late stage drug failures is the inability of drug candidates to imitate in humans the safety profile witnessed in animal models. Before introduction and acceptance of ADME toxicology testing, drug development process included toxicity and efficacy testing in in-vivo environment which was responsible for late stage failure of drugs in human body due to anatomical and genetic differences between animals and humans. To overcome this barrier of drug failure manufacturers across the globe opted for ADME toxicity testing in early drug developmental phases of pre-clinical trials. Increasing adoption of ADME toxicity testing as cost and time curbing tool is further expected to drive growth of this market. Introduction of technologically advanced computer based testing models are additionally fuelling growth of this market. According to market stakeholders, recently pre-clinical ADME toxicology testing is emerging to take on a new application in the drug-discovery venture capital (VC) industry’s financial decision that corresponds in importance and scope to its established role in the scientific decisions of drug discovery firms.

Market Competition Assessment
The ADME toxicology testing market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Cellartis AB, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Caliper Life Sciences, Inc., Promega Corporation, Cyprotex PLC, Beckman Coulter, Inc., Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., MultiCASE, Inc., Xceleron, Inc., ACEA Biosciences, Inc., Albany Molecular Research, Inc., and CeeTox, Inc.

Key Market Movements
  • Rising application of ADME toxicology testing by pharmaceuticals and biotechnology companies
  • Growing concerns over application of animals in clinical trials
  • Increase in demand of cell-based assays in drug discovery
  • Escalating adoption of ADME toxicity testing as cost and time curbing tool
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Beckman Coulter, Inc.
  • Cellartis AB
  • Cyprotex PLC
  • Molecular Discovery Ltd.
  • Promega Corporation
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 Usp and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Adme Toxicology Testing Market, by Product Type, 2015 (USD Mn)
2.2 Adme Toxicology Testing Market Share, by Technology Type, 2015 & 2022 (Value %)
2.3 Adme Toxicology Testing Market Share, by Geography, 2015 (Value %)

Chapter 3 Global Adme Toxicology Testing Market: Market Dynamics and Outlook
3.1 Adme Toxicology Testing: Current and Future Trends
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.6 Market Share Analysis: Key Adme Toxicology Testing Manufacturers, 2015 (%)

Chapter 4 Global Adme Toxicology Testing Market, by Product Type
4.1 Preface
4.2 Instruments
4.3 Software Solutions
4.4 Assays Systems
4.5 Reagents
4.6 Others

Chapter 5 Global Adme Toxicology Testing Market, by Technology Type
5.1 Preface
5.2 In-Vitro Tests
5.2.1 Biochemical Testing
5.2.2 Cell Testing
5.3 In-Vivo Tests

Chapter 6 Global Adme Toxicology Testing Market, by Geography
6.1 Preface
6.2 North America
6.2.1 U.S
6.2.2 Canada
6.3 Europe
6.3.1 U.K
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 China
6.4.2 Japan
6.4.3 Rest of Asia Pacific
6.5 Latin America (Latam)
6.5.1 Brazil
6.5.2 Mexico
6.5.3 Rest of Latam
6.6 Middle East and Africa (Mea)

Chapter 7 Future Growth Advocacies

Chapter 8 Company Profiles
8.1 Cellartis Ab
8.1.1 Business Description
8.1.2 Financial Health and Budget Allocation
8.1.3 Product Positions/Portfolio
8.1.4 Key Competitors
8.1.5 News Coverage
8.2 Thermo Fisher Scientific, Inc
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 Key Competitors
8.2.5 News Coverage
8.3 Agilent Technologies, Inc
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 Key Competitors
8.3.5 News Coverage
8.4 Bio-Rad Laboratories, Inc
8.4.1 Business Description
8.4.2 Financial Health and Budget Allocation
8.4.3 Product Positions/
8.4.4 Key Competitors
8.4.5 News Coverage
8.5 Caliper Life Sciences, Inc
8.5.1 Business Description
8.5.2 Financial Health and Budget Allocation
8.5.3 Product Positions/Portfolio
8.5.4 Key Competitors
8.5.5 News Coverage
8.6 Promega Corporation
8.6.1 Business Description
8.6.2 Financial Health and Budget Allocation
8.6.3 Product Positions/Portfolio
8.6.4 Key Competitors
8.6.5 News Coverage
8.7 Beckman Coulter, Inc
8.7.1 Business Description
8.7.2 Financial Health and Budget Allocation
8.7.3 Product Positions/Portfolio
8.7.4 Key Compsetitors
8.7.5 News Coverage
8.8 Optivia Biotechnology, Inc
8.8.1 Business Description
8.8.2 Financial Health and Budget Allocation
8.8.3 Product Positions/Portfolio
8.8.4 Key Competitors
8.8.5 News Coverage
8.9 Cyprotex Plc
8.9.1 Business Description
8.9.2 Financial Health and Budget Allocation
8.9.3 Product Positions/Portfolio
8.9.4 Key Competitors
8.9.5 News Coverage
8.10 Molecular Discovery Ltd
8.10.1 Business Description
8.10.2 Financial Health and Budget Allocation
8.10.3 Product Positions/Portfolio
8.10.4 Key Competitors
8.4.5 News Coverage

List of Figures
Figure 1 Adme Toxicology Testing: Market Segmentation
Figure 2 Adme Toxicology Testing Market, by Product Type, 2015 (USD Mn)
Figure 3 Adme Toxicology Testing Market Share, by Technology Type, 2015 & 2022 (Value %)
Figure 4 Adme Toxicology Testing Market Share, by Geography, 2015 (Value %)
Figure 5 Attractive Investment Proposition, Adme Toxicology Testing Market, 2015
Figure 6 Key Players Market Share Analysis for Adme Toxicology Testing, 2015 (%)
Figure 7 Global Instruments Market Revenue, 2013 - 2022 (USD Mn)
Figure 8 Global Software Solutions Market Revenue, 2013 - 2022 (USD Mn)
Figure 9 Global Assays Systems Market Revenue, 2013 - 2022 (USD Mn)
Figure 10 Global Reagents Market Revenue, 2013 - 2022 (USD Mn)
Figure 11 Global Others Market Revenue, 2013 - 2022 (USD Mn)
Figure 12 Global In-Vitro Tests Market Revenue, 2013 - 2022 (USD Mn)
Figure 13 Global In-Vivo Tests Market Revenue, 2013 - 2022 (USD Mn)
Figure 14 U.S. Adme Toxicology Testing Market Revenue, 2013 - 2022 (USD Mn)
Figure 15 Canada Adme Toxicology Testing Market Revenue, 2013 - 2022 (USD Mn)
Figure 16 U.K. Adme Toxicology Testing Market Revenue, 2013 - 2022 (USD Mn)
Figure 17 Germany Adme Toxicology Testing Market Revenue, 2013 - 2022 (USD Mn)
Figure 18 Rest of Europe Adme Toxicology Testing Market Revenue, 2013 - 2022 (USD Mn)
Figure 19 China Adme Toxicology Testing Market Revenue, 2013 - 2022 (USD Mn)
Figure 20 Japan Adme Toxicology Testing Market Revenue, 2013 - 2022 (USD Mn)
Figure 21 Rest of Asia-Pacific Adme Toxicology Testing Market Revenue, 2013 - 2022 (USD Mn)
Figure 22 Brazil Adme Toxicology Testing Market Revenue, 2013 - 2022 (USD Mn)
Figure 23 Mexico Adme Toxicology Testing Market Revenue, 2013 - 2022 (USD Mn)
Figure 24 Rest of Latam Adme Toxicology Testing Market Revenue, 2013 - 2022 (USD Mn)

List of Tables
Table 1 Global Adme Toxicology Testing Market Revenue, by Product Type, 2013 - 2022 (USD Mn)
Table 2 Global Adme Toxicology Testing Market Revenue, by Technology Type, 2013 - 2022 (USD Mn)
Table 3 Global Adme Toxicology Testing Market Revenue, by Geography, 2013 - 2022 (USD Mn)
Table 4 North America Adme Toxicology Testing Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 5 Europe Adme Toxicology Testing Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 6 Asia - Pacific Adme Toxicology Testing Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 7 Latin America Adme Toxicology Testing Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 8 Middle East and Africa Adme Toxicology Testing Market Revenue, by Region, 2013 - 2022 (USD Mn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Cellartis AB
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Caliper Life Sciences, Inc.
  • Promega Corporation
  • Beckman Coulter, Inc.
  • Optivia Biotechnology, Inc.
  • Cyprotex PLC
  • Molecular Discovery Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll